Study 13 of 47 for search of: "Aphasia"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Language in Primary Progressive Aphasia
This study is currently recruiting participants.
Verified by National Institute on Aging (NIA), December 2008
Sponsors and Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute on Aging (NIA)
Information provided by: National Institute on Aging (NIA)
ClinicalTrials.gov Identifier: NCT00537004
  Purpose

The purpose of this study is to further define the neurological and linguistic deterioration in primary progressive aphasia.


Condition
Primary Progressive Aphasia

MedlinePlus related topics: Aphasia Dementia
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Language in Primary Progressive Aphasia

Further study details as provided by National Institute on Aging (NIA):

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 120
Study Start Date: May 2007
Estimated Study Completion Date: April 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
PPA
Individuals with primary progressive aphasia
Control
Individuals with no diagnosis of any type of dementia

Detailed Description:

The study's main goal is to gain a better understanding of the progression and characterization of primary progressive aphasia (PPA). To do this, we look at many different aspects of the disease: neurological, defined by a clinical exam and MRI; neuropsychological, defined by a large battery of tests examining memory, attention, naming, and others; and linguistic, measured through picture, word, and sentence comprehension.

Volunteers with PPA will participate for three days; control volunteers will only participate for two. On the first day, each participant will come to the Chicago campus of Northwestern University to complete the neuropsychological testing battery developed by the researchers involved in the study. Also, on day one, the participant will be asked to have an MRI for imaging purposes.

On days two and three (or just day two, if a control participant), the participant will perform tasks on a computer in which they are presented with pictures on a screen and be asked to respond appropriately, based on study instructions. Also, the participant will be asked to perform a task while connected to an EEG to record event related potentials.

15 PPA and 15 Control participants will be recruited each year for four years. Those participating in years one and two will return in years three and four, respectively, to look at progression. Participants recruited in years three and four will only participate in the study once.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Primarily individuals enrolled in the Memory Research Core of NU's Cognitive Neurology and Alzheimer's Disease center. The minority are individuals who have contacted the Center for information about PPA research.

Criteria

Inclusion Criteria:

  • Diagnosis of primary progressive aphasia
  • Right-handed
  • English speaker
  • Visual acuity of 20/30 corrected
  • Adequate hearing to follow conversation

Exclusion Criteria:

  • Left-handedness
  • Claustrophobia
  • Presence of significant medical illness that initially or in the future could interfere with continued participation in the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00537004

Contacts
Contact: Christina Wieneke 312-908-9681 c-wieneke@northwestern.edu

Locations
United States, Illinois
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Christina Wieneke     312-908-9681     c-wieneke@northwestern.edu    
Principal Investigator: M.-Marsel Mesulam, MD            
Sub-Investigator: Sandra Weintraub, PhD            
Sponsors and Collaborators
Investigators
Principal Investigator: M.-Marsel Mesulam Northwestern University Feinberg School of Medicine
  More Information

Primary Progressive Aphasia (PPA) Research Program at Northwestern University  This link exits the ClinicalTrials.gov site

Publications:
Responsible Party: Northwestern University, Cognitive Neurology and Alzheimer's Disease Center ( Marsel Mesulam, MD, Professor )
Study ID Numbers: IA0125, 1RO1DC008552-01
Study First Received: September 26, 2007
Last Updated: December 29, 2008
ClinicalTrials.gov Identifier: NCT00537004  
Health Authority: United States: Federal Government

Keywords provided by National Institute on Aging (NIA):
Mesulam syndrome
dementia
Mild Cognitive Impairment

Study placed in the following topic categories:
Pick Disease of the Brain
Speech Disorders
Frontotemporal dementia
Aphasia
Language Disorders
Central Nervous System Diseases
Brain Diseases
Aphasia, Primary Progressive
Cognition Disorders
Signs and Symptoms
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Neurologic Manifestations
Lobar atrophy of brain
Primary progressive aphasia
Dementia
Neurobehavioral Manifestations
Pick disease of the brain
Communication Disorders
Delirium

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009